Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01087437
Other study ID # LAM002-HMO-CTIL
Secondary ID
Status Recruiting
Phase Phase 1
First received March 14, 2010
Last updated March 30, 2014
Start date January 2011

Study information

Verified date March 2014
Source Hadassah Medical Organization
Contact Ron Lamdan, M.D
Phone 972-2-6776342
Email ronl@hadassah.org.il
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

BACKGROUND: Distraction osteogenesis, the gradual lengthening of bones, is performed in order to equalize leg length discrepancy and correct skeletal deformities or to achieve greater height in short stature people. The femur and tibia are the bones most frequently lengthened. The surgery is currently performed at Hadassah Medical Center routinely by the pediatric orthopedic team utilizing a variety of external fixation devices.

The procedure involves application of an external fixation device to the bone, creation of an osteotomy and gradual, controlled distraction of the bone fragments On the last week of the distraction phase and every month thereafter, patients will be provided with a monthly supply of gastrolith calcium in a sealed container (65 capsules of 500 mg each, provided by Amorphical). Starting on the first day of the last week of the distraction phase, during the entire consolidation phase until the external fixator is removed; adults will orally consume two (2) 500 mg capsules a day (total of 1 gr of gastrolith calcium). Children will be given 25 mg calcium per kg body weight up to the daily adult dose of 1000mg .


Recruitment information / eligibility

Status Recruiting
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 4 Years to 30 Years
Eligibility Inclusion Criteria:

1. Males and females

2. Ages 4-30 years old.

Exclusion Criteria:

1. Product Allergy

2. Refusal to participate the study.

3. Metabolic Disorders

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Primary Purpose: Treatment


Intervention

Dietary Supplement:
gastrolith calcium


Locations

Country Name City State
Israel Hadassah Medical Organizaton Jerusalem

Sponsors (2)

Lead Sponsor Collaborator
Hadassah Medical Organization Amorfical

Country where clinical trial is conducted

Israel, 

See also
  Status Clinical Trial Phase
Completed NCT00155545 - Influence of Leg Length Discrepancy on the Spinal Shape and Biomechanics in Functional and Idiopathic Scoliosis Patients Phase 1
Recruiting NCT02095093 - An Intelligent Instrument for Improved Leg Length and Hip Offset Accuracy in Total Hip Arthroplasty N/A
Recruiting NCT02260856 - A Randomized Controlled Trial of Leg Length Discrepancy Techniques N/A
Completed NCT01625975 - Retrospective Eight Plate Study
Recruiting NCT03666975 - Can we Promote Bone Lengthening With Vibration Therapy? N/A